![]() |
|
by AFP Staff Writers Beijing (AFP) May 10, 2021
A unit of a Chinese giant Shanghai Fosun Pharmaceutical has agreed a $200 million joint-venture with Germany's BioNTech to make coronavirus vaccines, according to a company filing. Shanghai Fosun Pharmaceutical Industry Development will contribute up to $100 million in assets including cash and a manufacturing facility, capable of producing up to a billion jabs a year, according to the statement by the parent company on Sunday. The announcement comes after the United States backed a plan for a waiver on Covid-19 patent protections, in a bid to get the drugs to poorer countries -- sending shares in Asia-listed vaccine makers tumbling last week. Fosun said the joint venture firm for manufacturing and commercialising coronavirus vaccines will be owned 50 percent each by each company. The 15-year joint venture would be incorporated in Shanghai. BioNTech will contribute assets such as "licensing of the relevant manufacturing technology and know-how", the statement said.
Hong Kong's Joshua Wong handed extra jail time for Tiananmen vigil Hong Kong (AFP) May 6, 2021 Jailed Hong Kong dissident Joshua Wong was handed an additional 10-month sentence on Thursday after he pleaded guilty to taking part in an "unlawful" protest last year over the Tiananmen Square crackdown. Hong Kong has regularly marked the anniversary of Beijing's deadly 1989 repression of protests in Tiananmen Square with huge candlelight vigils. But last year's event was banned for the first time, with police citing the coronavirus pandemic and security fears following huge democracy protests ... read more
|
|||||||||||||
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |